Literature DB >> 7430122

Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid.

R L Wykle, B Malone, F Snyder.   

Abstract

1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine, derived chemically from choline plasmalogens of beef heart, has been shown to possess powerful antihypertensive activity (Blank, M. L., Synder, F., Byers, L. W., Brooks, B., and Muirhead, E. E. (1979) Biochem. Biophys. Res. Commun. 90, 1194-1200) and to be an extremely potent platelet-activating factor (Demopoulos, C. C., Pinckard, R. N., and Hanahan, D. J. (1979) J. Biol. Chem. 254, 9355-9358). In the present study, microsomal preparations of rat spleen were shown to synthesize 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine by an acetyl-CoA:1-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase reaction; the acetyltransferase appears to be different from the acyltransferase responsible for the transfer of palmitate to glycerolipids. The apparent Km for acetyl-CoA was 67 microM; the optimal concentration of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine was 30 microM. Higher concentrations of the lyso substrate were inhibitory. When acetyl-CoA (100 microM) and 1-hexadecyl-sn-glycero-3-phosphocholine (30 microM) were incubated wih spleen microsomes under optimal conditions, the specific activity was approximately 10 nmol of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine/min/mg of protein. Although the reaction was inhibited by the addition of EDTA or EGTA to the incubation mixture, the acetyltransferase did not appear to require a divalent cation. An acyl analog, 1-palmitoyl-2-lyso-sn-glycero-3-phosphocholine, also served as a substrate for the acetyltransferase; however, the unnatural isomer, 3-alkyl-2-lyso-sn-glycero-1-phosphocholine, did not. The acetyltransferase activity was found in a variety of tissues, but the spleen had the highest activity of the tissues examined; lung, lymph nodes, and thymus also had high activities. Identification of the product and the possible physiological importance of the pathway are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7430122

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  Lipid acetylation reactions and the metabolism of platelet-activating factor.

Authors:  R R Baker
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

2.  Calcium-dependent biosynthesis of platelet-activating factor by submandibular gland cells.

Authors:  T Dohi; K Morita; S Kitayama; A Tsujimoto
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

3.  Regulation of the biosynthesis of platelet-activating factor in alveolar macrophages.

Authors:  T Sugiura; A Ojima-Uchiyama; Y Masuzawa; M Fujita; Y Nakagawa; K Waku
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  Kinetic studies of human and rat neutrophil lysoPAF acetyltransferase using lysoPAF and dansyllysoPAF as substrates.

Authors:  P W Schindler; E Ninio
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

5.  Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked.

Authors:  L Touqui; M Hatmi; B B Vargaftig
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

6.  Biosynthesis of paf-acether. Paf-acether but not leukotriene C4 production is impaired in cultured macrophages.

Authors:  A Dulioust; E Vivier; N Meslier; R Roubin; I Haye-Legrand; J Benveniste
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

7.  Arachidonyl transfer from diacyl phosphatidylcholine to ether phospholipids in rat platelets.

Authors:  O Colard; M Breton; G Bereziat
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

8.  Signaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells.

Authors:  Jie Ma; Karen M Harnett; Jose Behar; Piero Biancani; Weibiao Cao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-12-03       Impact factor: 4.052

9.  Metabolism of platelet-activating factor in human haematopoietic cell lines. Differences between myeloid and lymphoid cells.

Authors:  M C Garcia; C Garcia; M A Gijon; S Fernandez-Gallardo; F Mollinedo; M Sanchez Crespo
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

10.  Enhancement by cyclo-oxygenase inhibitors of platelet-activating factor production in thapsigargin-stimulated macrophages.

Authors:  M Watanabe; M Yamada; S Mue; K Ohuchi
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.